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Objective: To describe the prevalence of the CF pathogens Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae in OP
cultures from healthy children.
Methods: Oropharyngeal (OP) swabs were collected from 100 healthy children ≤18 years of age undergoing a clinically indicated procedure.
Results: P. aeruginosa was isolated from the OP swab of one participant, S. aureus from 48 participants (including 4 methicillin-resistant) and
H. influenzae from 47 participants. Cultures from 75 participants grew one or more of these organisms (55 grew one, 19 grew 2 and one grew 3 organisms).
Conclusion: P. aeruginosa is rarely recovered from the oropharynx of healthy children≤18 years of age, while recovery of S. aureus andH. influenzae
is common. It is important to understand what the “normal” prevalence of CF pathogens is in the oropharynx in order to aid interpretation of OP cultures
in CF patients.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.1. Introduction
The U.S. Cystic Fibrosis Foundation recommends obtaining
respiratory cultures from CF patients at least quarterly to monitor
for respiratory pathogens. In patients in the U.S. who cannot
expectorate, these cultures are generally obtained from oropha-
ryngeal (OP) swabs. While one prior study reported OP flora in
healthy infants [1], to our knowledge there has been no prior
systematic evaluation of OP flora from a broader age range of
healthy children. Understanding the prevalence of CF pathogens
in the oropharynx of healthy children would aid in the
interpretation of culture results from CF patients. Our objective
was to describe the prevalence of the CF pathogens Pseudomonas☆ Prior presentation: Rosenfeld, M, Bernardo-Ocampo C, Emerson J, Khan
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in OP cultures from children without known risk factors for
Pseudomonas infection such as immunosuppression, recent
antibiotic exposure, or indwelling catheters or devices.2. Methods
We enrolled 100 children ≤18 years of age undergoing a
clinically indicated procedure that required sedation or anesthesia
at Seattle Children's Hospital, Seattle, WA, USA between
September 2008 and February 2010. Exclusion criteria
included: (1) Presence of indwelling catheters or devices
(including myringotomy tubes) at enrollment or within the past
year; (2) oral or IV antibiotic treatment within the past month;
(3) presence of congenital or acquired immunosuppression; (4)
history of cancer; (5) currently undergoing an otolaryngology
or dental procedure; (6) immediate family member has CF; and
(7) blood transfusion within the past year. An OP swab was
collected from each participant and sent on the day of collectionby Elsevier B.V. All rights reserved.
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Microbiology (at the same institution) for culture. Specimens
were directly plated on blood, MacConkey, mannitol salt and
Haemophilus selective agars, the latter three media for
P. aeruginosa, S. aureus, and H. influenzae, respectively.
Organisms were identified according to standard biochemical
methods and methicillin resistant S. aureus was determined by
oxacillin disc. The study was approved by the Seattle Children's
Hospital IRB and informed consent was obtained from all
parents/guardians, as well as assent from participants as
applicable.
3. Results
Participants had a mean (SD) age of 8.6 (5.5) years, range
0.2 to 18 years; 41 were female and 59 male. OP cultures were
obtained from 99 participants. P. aeruginosa was isolated from
the OP swab of one participant, S. aureus from 48 participants
(including 4 methicillin-resistant) and H. influenzae from 47
participants. Cultures from 75 participants grew one or more of
these organisms (55 grew one, 19 grew 2 and one grew 3
organisms).
4. Discussion
Our results indicate that P. aeruginosa is rarely recovered
from the oropharynx of healthy children ≤18 years of age
(prevalence 1%), while recovery of S. aureus (48%) and
H. influenzae (47%) is common. In 83 healthy infants b1 year
of age, Carlson, et al. cultured P. aeruginosa from 4%,
S. aureus from 27% and H. influenzae from 11% [1],
suggesting that P. aeruginosa is also rarely isolated from the
oropharynx of healthy infants. The slightly higher prevalence
of P. aeruginosa in that infant cohort may reflect greater fecal–
oral transmission of P. aeruginosa in infants [2].
In CF patients, OP cultures have limited sensitivity though
reasonable specificity for the detection of P. aeruginosa and
S. aureus in the lower airway [3]. Thus, it is important to
understand what the “normal” prevalence of CF pathogens is in
the oropharynx in order to aid interpretation of OP cultures in
CF patients. Our results suggest that isolation of P. aeruginosa
from an OP culture in a CF patient likely reflects the CF disease
process and should be treated accordingly. S. aureus, while a
known CF pathogen, is commonly isolated from the oropharynx
of otherwise healthy children, complicating the interpretation of a
positive OP culture in CF patients. In CF patients with an initialor chronically positive OP culture and new respiratory signs or
symptoms, treatment with anti-staphyloccocal antibiotics is
considered standard of care. Indeed, in many countries, anti-
staphyloccocal prophylaxis is standard of care in the first two
years of life [4]. Given the high prevalence of S. aureus in the
oropharynx of healthy children, obtaining a lower airway sample
should be considered in a CF patient with an initial positive OP
culture in whom such information would change treatment. The
role of H. influenzae as a pathogen in CF is less clear than that of
S. aureus. Nonetheless, similar to S. aureus, in CF patients with a
positive OP culture and new respiratory signs or symptoms,
treatment with antibiotics directed against H. influenzae is
considered standard of care. It should also be noted that, in
contrast to the participants in the current study who by design had
not been recently exposed to antibiotics, CF patients are frequently
treated with antibiotics directed against organisms isolated from
respiratory cultures. A positive culture from a recently treated CF
patient may represent a treatment failure and a change in
antibiotics may be warranted.
In our study, specimens were obtained from children
undergoing sedation/anesthesia. While our eligibility criteria
aimed to exclude children with chronic medical conditions,
particularly those that might increase the risk of P. aeruginosa
infection, study participants by definition had conditions requiring
a procedure. In addition, the more vigorous oropharyngeal
swabbing that can be performed under sedation may have
increased the culture yield. Both of these factors would have the
effect of increasing the apparent prevalence of oropharyngeal
pathogens. The true prevalence of P. aeruginosa in the
oropharynx of healthy children in the community may be even
lower than our observed rate of 1%. Thus, isolation of
P. aeruginosa from an OP culture in a CF patient likely reflects
the CF disease process.References
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